TY - JOUR
T1 - Neuropsychological phenotypic characteristics in a cohort of community-based older adults
T2 - Data from the Framingham Heart Study
AU - De Anda-Duran, Ileana
AU - Hwang, Phillip H.
AU - Drabick, Deborah A.G.
AU - Andersen, Stacy L.
AU - Au, Rhoda
AU - Libon, David J.
N1 - Publisher Copyright:
© The Author(s) 2025
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Background: Neuropsychological (NP) assessment is crucial for diagnosing prodromal and Alzheimer's disease and related dementia (ADRD) syndromes. Yet, traditional NP scores often overlook errors and the process by which summary scores are obtained; information that can provide deeper insights into cognitive impairments and clinical heterogeneity. Objective: To classify community-dwelling adults into neurocognitive phenotypes, identify NP test errors and processes that differentiate between groups, and explore their association with brain imaging measures. Methods: Framingham Heart Study (FHS) data were analyzed, focusing on NP summary scores and errors derived from the Boston Process Approach. Latent class analysis identified distinct neurocognitive phenotypes. Regression analyses assessed the relationships with NP errors and brain MRI measures. Results: A total of 1195 participants (mean age 69.6 and 56.3% women) were included. Cognitively normal (CN), moderate-mixed, and dysexecutive impairment groups were identified. The number of Trail Making Test – Part B (TMT-B) pen lifts and TMT-B examiner-corrected errors were associated with the dysexecutive phenotype and differentiated it from the CN group (OR = 1.39, 95% CI = 1.28–1.52, p < 0.001, AUC = 0.85 and OR = 3.40, 95% CI = 2.65–4.38, p < 0.001, AUC = 0.92; respectively). Similarly, Boston Naming Test (BNT) circumlocution errors were associated with the moderate-mixed phenotype and differentiated it from the CN group (OR = 1.87, 95% CI = 1.49–2.35, p < 0.001, AUC = 0.81). These scores were significantly associated with reduced hippocampal volumes. Conclusions: Detailed NP error and process analysis enhances traditional methods, offering a comprehensive approach to identifying and understanding cognitive impairments.
AB - Background: Neuropsychological (NP) assessment is crucial for diagnosing prodromal and Alzheimer's disease and related dementia (ADRD) syndromes. Yet, traditional NP scores often overlook errors and the process by which summary scores are obtained; information that can provide deeper insights into cognitive impairments and clinical heterogeneity. Objective: To classify community-dwelling adults into neurocognitive phenotypes, identify NP test errors and processes that differentiate between groups, and explore their association with brain imaging measures. Methods: Framingham Heart Study (FHS) data were analyzed, focusing on NP summary scores and errors derived from the Boston Process Approach. Latent class analysis identified distinct neurocognitive phenotypes. Regression analyses assessed the relationships with NP errors and brain MRI measures. Results: A total of 1195 participants (mean age 69.6 and 56.3% women) were included. Cognitively normal (CN), moderate-mixed, and dysexecutive impairment groups were identified. The number of Trail Making Test – Part B (TMT-B) pen lifts and TMT-B examiner-corrected errors were associated with the dysexecutive phenotype and differentiated it from the CN group (OR = 1.39, 95% CI = 1.28–1.52, p < 0.001, AUC = 0.85 and OR = 3.40, 95% CI = 2.65–4.38, p < 0.001, AUC = 0.92; respectively). Similarly, Boston Naming Test (BNT) circumlocution errors were associated with the moderate-mixed phenotype and differentiated it from the CN group (OR = 1.87, 95% CI = 1.49–2.35, p < 0.001, AUC = 0.81). These scores were significantly associated with reduced hippocampal volumes. Conclusions: Detailed NP error and process analysis enhances traditional methods, offering a comprehensive approach to identifying and understanding cognitive impairments.
UR - https://www.scopus.com/pages/publications/105009268531
UR - https://www.scopus.com/pages/publications/105009268531#tab=citedBy
U2 - 10.1177/13872877251334608
DO - 10.1177/13872877251334608
M3 - Article
C2 - 40267270
AN - SCOPUS:105009268531
SN - 1387-2877
VL - 105
SP - 1447
EP - 1459
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 4
ER -